Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30345% above fair value
$14.80+0.00 (0.00%)
Close on Nov 17, 2026Market cap $1.58BP/E –Yield –
Personalis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Personalis's operating cash flow for the twelve months ending Jun 30, 2026 was -$92.30M. For fiscal 2025 it was -$74.95M. The highest annual figure on record is $5.57M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$74.95M | – |
| FY2024 | Dec 31, 2024 | -$45.15M | – |
| FY2023 | Dec 31, 2023 | -$56.26M | – |
| FY2022 | Dec 31, 2022 | -$70.23M | – |
| FY2021 | Dec 31, 2021 | -$70.83M | – |
| FY2020 | Dec 31, 2020 | -$42.65M | – |
| FY2019 | Dec 31, 2019 | -$18.07M | -424.3% |
| FY2018 | Dec 31, 2018 | $5.57M | +1821.4% |
| FY2017 | Dec 31, 2017 | $290.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$25.77M | – |
| Q1 FY2026 | Mar 31, 2026 | -$22.48M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.25M | – |
| Q3 FY2025 | Sep 30, 2025 | -$21.80M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.94M | – |
| Q1 FY2025 | Mar 31, 2025 | -$17.96M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.80M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.74M | – |
| Q1 FY2024 | Mar 31, 2024 | -$20.41M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.42M | – |
| Q3 FY2023 | Sep 30, 2023 | -$16.68M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.41M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.75M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.76M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.77M | – |
| Q2 FY2022 | Jun 30, 2022 | -$27.35M | – |
| Q1 FY2022 | Mar 31, 2022 | -$11.36M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.27M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.88M | – |
| Q2 FY2021 | Jun 30, 2021 | -$25.93M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.74M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.53M | -205.3% |
| Q3 FY2020 | Sep 30, 2020 | -$16.12M | – |
| Q2 FY2020 | Jun 30, 2020 | -$15.35M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.64M | -13195.5% |
| Q4 FY2019 | Dec 31, 2019 | $2.41M | -24.9% |
| Q3 FY2019 | Sep 30, 2019 | -$9.64M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.90M | – |
| Q1 FY2019 | Mar 31, 2019 | $66.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $3.20M | – |
| Q3 FY2018 | Sep 30, 2018 | -$431.00K | – |
See a number that looks wrong?